Chongkundang Holdings Corp operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongkundang Holdings Corp with three other
companies in this sector in KOREA (SOUTH) :
Dong A St Co Ltd
sales of 567.43 billion Korean Won [US$457.35 million]
of which 59%
was Finished Goods),
Boryung Pharmaceutical Company Limited
(460.40 billion Korean Won [US$371.08 million]
of which 51%
was Finished Goods), and
JW Pharmaceutical Corp
(537.18 billion Korean Won [US$432.97 million]
of which 100%
was Pharmaceutical Industry).
During the year ended December of 2018, sales at
Chongkundang Holdings Corp were 531.11 billion Korean Won (US$428.08 million).
increase of 17.8%
versus 2017, when the company's sales were 450.74 billion Korean Won .
This was the fourth straight year of sales growth at Chongkundang Holdings Corp.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Chongkundang Holdings Corp had sales
of 560.48 billion Korean Won .
Sales of Other Segment saw an increase
that was more than double the company's growth rate: sales were up
124.3% in 2018, from
28.97 billion Korean Won to 64.99 billion Korean Won .